Benitec Biopharma
$10.65
19
+$0.59+5.86% Tuesday 20:00
Statistics
Day High
10.86
Day Low
10.17
52W High
17.15
52W Low
9.85
Volume
136,012
Avg. Volume
165,005
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.275
Actual EPS
N/A
Financials
-24,942.47%Profit Margin
Unprofitable73,000Revenue
-18.21MNet Income
Analyst Ratings
$27.00Average Price Target
The highest estimate is 32.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BNTC. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Ionis Pharmaceuticals
IONS
Mkt Cap12.03B
Arrowhead Pharmaceuticals
ARWR
Mkt Cap5.86B
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
Editas Medicine
EDIT
Mkt Cap276.95M
Intellia Therapeutics
NTLA
Mkt Cap1.35B
About
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Show more...
CEO
Dr. Jerel A. Banks M.D., Ph.D.
Employees
16
Country
US
ISIN
US08205P2092
Listings
0 Comments
Share your thoughts
FAQ
What is Benitec Biopharma stock price today?▼
The current price of BNTC is $10.65 USD — it has increased by +5.86% in the past 24 hours. Watch Benitec Biopharma stock price performance more closely on the chart.
What is Benitec Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Benitec Biopharma stocks are traded under the ticker BNTC.
Is Benitec Biopharma stock price growing?▼
BNTC stock has fallen by -1.75% compared to the previous week, the month change is a -2.29% fall, over the last year Benitec Biopharma has showed a -11.4% decrease.
When is the next Benitec Biopharma earnings date?▼
Benitec Biopharma is going to release the next earnings report on May 18, 2026.
What were Benitec Biopharma earnings last quarter?▼
BNTC earnings for the last quarter are -0.26 USD per share, whereas the estimation was -0.22 USD resulting in a -16.42% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Benitec Biopharma revenue for the last year?▼
Benitec Biopharma revenue for the last year amounts to 73,000 USD.
What is Benitec Biopharma net income for the last year?▼
BNTC net income for the last year is -18.21M USD.
How many employees does Benitec Biopharma have?▼
As of April 01, 2026, the company has 16 employees.
In which sector is Benitec Biopharma located?▼
Benitec Biopharma operates in the Health Care sector.
When did Benitec Biopharma complete a stock split?▼
The last stock split for Benitec Biopharma was on July 26, 2023 with a ratio of 1:17.
Where is Benitec Biopharma headquartered?▼
Benitec Biopharma is headquartered in Hayward, US.